NYMC Faculty Publications
Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines
DOI
10.1007/s40265-018-0887-5
Journal Title
Drugs
First Page
567
Last Page
576
Document Type
Article
Publication Date
April 2018
Department
Medicine
Keywords
Blood Pressure, Cardiovascular Agents, Hypertension
Disciplines
Medicine and Health Sciences
Abstract
The 2017 American College of Cardiology/American Heart Association hypertension guidelines diagnose hypertension if systolic blood pressure (SBP) is >/= 130 mmHg or diastolic blood pressure (DBP) is >/= 80 mmHg. Increased BP is SBP 120-129 mmHg with DBP /= 130 mmHg or an average DBP >/= 80 mmHg. Lifestyle measures plus BP-lowering drugs should be used for primary prevention of cardiovascular disease in individuals with an estimated 10-year risk of atherosclerotic cardiovascular disease (ASCVD) >/= 10% and an average SBP >/= 130 mmHg or an average DBP >/= 80 mmHg. Lifestyle measures plus BP-lowering drugs should be used for primary prevention of cardiovascular disease in individuals with an estimated 10-year risk of ASCVD /= 140 mmHg or an average DBP >/= 90 mmHg. White coat hypertension must be excluded before starting antihypertensive drug treatment in individuals with hypertension with a low risk for ASCVD. BP should be lowered to 65 years. The selection of antihypertensive drug treatment is discussed.
Recommended Citation
Aronow, W. S., & Frishman, W. H. (2018). Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines. Drugs, 78 (5), 567-576. https://doi.org/10.1007/s40265-018-0887-5
